About Viyash Scientific Ltd
Viyash Scientific is a leading integrated pharmaceutical Company with a global footprint, operating in the domains of Animal and Human Health (APIs and finished dosage formulations).
Founded
1985
CEO
Kamal K Sharma
Employees
4,131
HQ
Bangalore, India
Finished Products
1Sales
₹2,489.87Cr2Bulk Drugs
₹828.07Cr3Sale of Services
₹163.88Cr4Duty drawback received
₹39.51Cr5Processing charges
₹24.86Cr6Bulk Drugs-Traded
₹11.12Cr7Chemical-Traded
₹8.57Cr1–7 of 9
Raw Materials
1Cost of Material Consumed
₹1,164.90Cr2Chemicals
₹265.76Cr3Solvents
₹74.86Cr4Finished Goods Purchases
₹34.48Cr5Chemicals-Purchased
₹4.19Cr6Purchases of Stock in Trade
₹2.42Cr7Bulk Drugs-Purchases
₹0.19CrAbout Viyash Scientific Ltd
Viyash Scientific is a leading integrated pharmaceutical Company with a global footprint, operating in the domains of Animal and Human Health (APIs and finished dosage formulations).
Founded:1985
CEO:Kamal K Sharma
Employees:4,131
HQ:Bangalore, India
Finished Products
1Sales
₹2,489.87Cr2Bulk Drugs
₹828.07Cr3Sale of Services
₹163.88Cr4Duty drawback received
₹39.51Cr5Processing charges
₹24.86Cr6Bulk Drugs-Traded
₹11.12Cr7Chemical-Traded
₹8.57Cr1–7 of 9
Raw Materials
1Cost of Material Consumed
₹1,164.90Cr2Chemicals
₹265.76Cr3Solvents
₹74.86Cr4Finished Goods Purchases
₹34.48Cr5Chemicals-Purchased
₹4.19Cr6Purchases of Stock in Trade
₹2.42Cr7Bulk Drugs-Purchases
₹0.19CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹298
52W Low
₹170
Volume3.33M
Avg VolumeN/A
Beta1.38
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
42.69x
Valuation
P/B Ratio
4.04x
Valuation
EPS
₹6.07
Valuation
Dividend Yield
0.00%
Valuation
ROE
7.07%
Profitability
ROCE
13.01%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals
+44.8%98.8%
₹626.59 Cr
Analytical Services
-25.5%1.2%
₹7.89 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
26.5%
International
73.5%
Rest of the world48.5%
India26.5%
USA14.3%
Spain10.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
35.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.